Jaser N
Second Department of Surgery, Helsinki University Central Hospital, Finland.
Ann Chir Gynaecol. 1993;82(1):7-16.
During the period of 1978-1988, 36 patients were treated for primary gastrointestinal non-Hodgkin's lymphoma (PGIL) at the Second Department of Surgery, Helsinki University Central Hospital. There were 16 gastric, 15 small intestinal, four large bowel lymphomas, and one case of diffuse multiple lymphomatous polyposis (MLP) of the gastrointestinal tract. Most frequently the disease occurred in middle-aged patients equally in both sexes. Symptoms were non-specific. Abdominal pain was the most common symptom occurring in 30 patients (83%), followed by nausea in 17 patients (47%). Fever occurred in seven patients (20%). Bleeding occurred in ten patients (28%), obstruction in five (14%), and perforation in three patients (8%). An abdominal mass was felt in ten patients (28%). Radiological findings were mostly non-specific but suggested malignant tumour. A definitive diagnosis was difficult to confirm by endoscopic examination. Thirty-five patients underwent surgery, curative in 19 (12 gastric, five small intestine lymphomas (SIL), two large intestine lymphomas (LIL)), and palliative in 12 patients (two gastric, eight SIL, one LIL, and one case of MLP). One patient (gastric) underwent exploration and three had other procedures (two SIL, one LIL). 89% of the patients who had a curative resection survived five years, compared with 28% of those who had palliative resection. The stage of the disease was a very important prognostic factor: the five-year survival was 92% for patients with Stage I disease, while none of the patients with Stage IV disease survived five years. Also, adjuvant therapy was a statistically significant variable affecting survival, and the site of the tumour. Patients with gastric lymphoma had better survival than those with small and large intestinal lymphoma.
1978年至1988年期间,赫尔辛基大学中心医院第二外科收治了36例原发性胃肠道非霍奇金淋巴瘤(PGIL)患者。其中16例为胃淋巴瘤,15例为小肠淋巴瘤,4例为大肠淋巴瘤,1例为胃肠道弥漫性多发性淋巴瘤性息肉病(MLP)。该疾病最常发生于中年患者,男女发病率相当。症状无特异性。腹痛是最常见的症状,30例患者(83%)出现腹痛,其次是17例患者(47%)出现恶心。7例患者(20%)发热。10例患者(28%)出血,5例患者(14%)梗阻,3例患者(8%)穿孔。10例患者(28%)可触及腹部肿块。影像学检查结果大多无特异性,但提示为恶性肿瘤。通过内镜检查很难确诊。35例患者接受了手术,19例为根治性手术(12例胃淋巴瘤、5例小肠淋巴瘤(SIL)、2例大肠淋巴瘤(LIL)),12例为姑息性手术(2例胃淋巴瘤、8例SIL、1例LIL和1例MLP)。1例患者(胃淋巴瘤)接受了探查,3例患者接受了其他手术(2例SIL、1例LIL)。接受根治性切除的患者中有89%存活了5年,而接受姑息性切除的患者中这一比例为28%。疾病分期是一个非常重要的预后因素:I期疾病患者的5年生存率为92%,而IV期疾病患者无一人存活5年。此外,辅助治疗是影响生存的一个具有统计学意义的变量,肿瘤部位也是如此。胃淋巴瘤患者的生存率高于小肠和大肠淋巴瘤患者。